ALSERES PHARMACEUTICALS INC /DE
CIK 0000094784
Revenue (TTM)
$73.73K
−10.7% YoY
Q2 Jul 2014
Net Income (TTM)
−$1.54M
+42.8% YoY
Q2 Jul 2014
EPS Diluted (TTM)
−$0.10
Q2 Jul 2014
Gross Margin
—
Q2 Jul 2014
Operating Margin
-1,758.8%
Q2 Jul 2014
Net Margin
-2,083.0%
Q2 Jul 2014
Free Cash Flow (TTM)
−$3.44M
Q2 Jul 2014
Cash
$46.44K
Q2 Jul 2014
Total Debt
—
Q2 Jul 2014
Shares Outstanding
30.64M sh
Q2 Jul 2014